Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent chronic liver disorders worldwide. It is closely associated with metabolic syndrome components, including type 2 diabetes, hyperlipidaemia and obesity. To date, no effective drug treatment is available for NAFLD but several clinic...
Saved in:
Main Author: | Tanyaporn Chantarojanasiri (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of silymarin on non-alcoholic fatty liver disease of children
by: Fatemeh Famouri, et al.
Published: (2017) -
Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report
by: Ahmed Hashem
Published: (2023) -
Silymarin in the management of liver enzyme activity in steatohepatitis: a case report
by: Aldo Torre
Published: (2023) -
Comparing Effects of Medication Therapy and Exercise Training with Diet on Liver enzyme Levels and Liver Sonography in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Azadeh Nabizadeh Haghighi, et al.
Published: (2015) -
Effects of Nonlinear Resistance Training with Curcumin Supplement on Liver Enzymes in Men with Non- Alcoholic Fatty Liver Disease
by: Baharak Moradi Kelardeh, et al.
Published: (2017)